Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.35
+3.6%
$0.29
$0.23
$1.40
$13.61M0.781.01 million shs361,704 shs
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$0.42
-12.3%
$0.41
$0.25
$1.24
$13.54M0.79207,864 shs211,940 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$4.33
-0.5%
$3.36
$1.71
$8.60
$11.95M0.72802,763 shs64,278 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.28
-2.1%
$2.45
$2.10
$14.50
$3.24M0.09937,297 shs12,820 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
0.00%+10.10%+15.94%+25.87%-73.96%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00%+32.58%+24.40%+30.78%-54.78%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.00%-21.05%+43.09%+27.19%+6.88%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%+2.19%+0.43%-6.05%-61.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.35
+3.6%
$0.29
$0.23
$1.40
$13.61M0.781.01 million shs361,704 shs
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$0.42
-12.3%
$0.41
$0.25
$1.24
$13.54M0.79207,864 shs211,940 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$4.33
-0.5%
$3.36
$1.71
$8.60
$11.95M0.72802,763 shs64,278 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.28
-2.1%
$2.45
$2.10
$14.50
$3.24M0.09937,297 shs12,820 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
0.00%+10.10%+15.94%+25.87%-73.96%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00%+32.58%+24.40%+30.78%-54.78%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.00%-21.05%+43.09%+27.19%+6.88%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%+2.19%+0.43%-6.05%-61.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
3.00
Buy$5.501,444.94% Upside
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
3.00
Buy$28.00546.65% Upside
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VERO, MHUA, CODX, and SINT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$3.91M3.51N/AN/A$1.70 per share0.21
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$96.90M0.14$0.40 per share1.07$6.34 per share0.07
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.89M4.14N/AN/A$2.90 per share1.49
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.05N/AN/A$4.30 per share0.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$10.84MN/A0.00N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$11.02M-$50.56N/AN/A-674.05%-256.59%-121.32%11/11/2025 (Estimated)
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$50.78N/AN/A-68.77%-871.77%-61.92%11/13/2025 (Estimated)

Latest VERO, MHUA, CODX, and SINT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million
8/14/2025Q2 2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$0.79-$0.91-$0.12-$0.91$0.40 million$0.15 million
8/14/2025Q2 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$9.72-$8.03+$1.69-$8.03$14.01 million$15.69 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
4.12
3.83
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/A
5.26
5.21
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
2.57
2.41
Venus Concept Inc. stock logo
VERO
Venus Concept
5.72
1.10
0.71

Institutional Ownership

CompanyInstitutional Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
1.17%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
10038.52 million36.17 millionOptionable
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
62031.90 million10.67 millionNot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
402.76 million2.65 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

Venus Concept Inc. (NASDAQ:VERO) Sees Large Decline in Short Interest
Venus Concept Secures $2M Loan for Operations
Venus Concept Amends Loan Agreements for Financial Relief
VERO - Venus Concept Inc Financials - Morningstar
Venus Concept Inc News (VERO) - Investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.35 +0.01 (+3.61%)
Closing price 03:59 PM Eastern
Extended Trading
$0.35 0.00 (-0.40%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Meihua International Medical Technologies stock logo

Meihua International Medical Technologies NASDAQ:MHUA

$0.42 -0.06 (-12.32%)
Closing price 04:00 PM Eastern
Extended Trading
$0.45 +0.02 (+5.35%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Sintx Technologies stock logo

Sintx Technologies NASDAQ:SINT

$4.33 -0.02 (-0.46%)
Closing price 04:00 PM Eastern
Extended Trading
$4.31 -0.02 (-0.46%)
As of 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.28 -0.05 (-2.15%)
Closing price 04:00 PM Eastern
Extended Trading
$2.44 +0.17 (+7.24%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.